NMN Is Legal Again - Here's What Men on TRT Actually Need to Know

[Nelson Vergel]

Key Takeaways

• NAD+ declines 10-50% between young adulthood and the mid-50s; this decline is independent of testosterone and affects energy, DNA repair, and immune function.
• A 2024 systematic review of 10 RCTs found NMN reliably improves physical performance in adults over 50, with a clean safety profile at doses of 150-1,200 mg per day.
• NMN was confirmed lawful as a US dietary supplement on September 29, 2025, ending three years of regulatory uncertainty.
• Preclinical (animal) data from patent AU2020367387A1 shows NMN matches dexamethasone for joint swelling reduction in a rheumatoid arthritis model - without the weight loss and catabolic side effects. No human RA trials exist yet.
• NMNH (dihydronicotinamide mononucleotide) is up to 10x more potent than NMN in preclinical studies but has limited human data and no FDA NDI clearance yet.
• NMN does not raise testosterone - its value on TRT comes from the cellular energy system that operates beneath the hormonal layer.

Curated By Nelson Vergel | ExcelMale.com | Updated June 2026

Men on TRT who explore longevity supplementation run into NMN constantly. David Sinclair mentions it in nearly every interview. Supplement companies market it alongside resveratrol and berberine in expensive stacks. The ExcelMale community has been debating it since 2019 - most of those conversations stayed inconclusive, partly because the regulatory situation was genuinely murky until late 2025.

That changed. On September 29, 2025, the FDA formally confirmed that NMN is lawful as a dietary supplement in the United States, ending three years of confusion triggered by its investigation as a drug. The human clinical trial database has also grown meaningfully since the early debates. So does the evidence now support adding NMN to a TRT protocol? That depends on what you are trying to accomplish - and on being honest about what the research actually shows versus what the marketing says.

Why Does NAD+ Drop as Men Age, and Why Does It Matter More After 40?​

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme that every cell in your body requires for energy production, DNA repair, and communication between the mitochondria and nucleus. Sirtuins - the enzymes that regulate cellular stress response and longevity pathways - run on NAD+. PARP1, which repairs DNA strand breaks, also consumes it at a high rate.

Blood NAD+ concentrations decline measurably with age. Estimates from published research put the decline at 10 to 50% lower by the time men reach their 50s and 60s compared to young adults (Imai and Guarente, Trends Cell Biol, 2014). The drop accelerates in men with metabolic issues, chronic inflammation, or high alcohol intake.

For men on TRT, there is a parallel consideration. Testosterone therapy addresses the hormonal side of aging, but it does not directly restore cellular energy pathways. NAD+ operates through a different mechanism - at the mitochondrial level, supporting the electron transport chain and the ATP production that underlies everything from muscle contraction to immune cell activity. Optimizing both the hormonal and cellular energy layers is the rationale behind adding NAD+ precursors to a TRT stack.

How Does NMN Raise NAD+ Levels?​

NMN is a nucleotide - it carries a phosphate group that prevents direct entry through most cell membranes. Before entering cells, NMN sheds that phosphate and converts to nicotinamide riboside (NR), then re-phosphorylates back to NMN inside the cell, and finally converts to NAD+.

This conversion sequence is relevant to the ongoing ExcelMale community debate about whether simple niacinamide (nicotinamide) - a much cheaper vitamin B3 form - achieves similar results, since niacinamide also feeds the same NAD+ salvage pathway. The mechanistic argument for niacinamide is legitimate, particularly for younger men with healthy metabolisms. Several researchers argue that age-related declines in the conversion enzymes make higher-tier precursors like NMN or NR a better choice for men over 50.

What Do the Human Clinical Trials Actually Show About NMN?​

The honest summary: the human evidence is real and growing, but more modest than the supplement marketing suggests.

What Did the 2024 Systematic Review Find?​

A 2024 systematic review published in Cureus by Wen and colleagues analyzed 10 randomized controlled trials involving 437 patients. The mean participant age was 58 years, and follow-up periods ran 4 to 12 weeks. NMN dosages ranged from 150 to 1,200 mg per day. The review found that NMN positively affected physical performance parameters - including grip strength and walking speed - with a consistently clean safety profile across all included studies (Wen et al., Cureus, 2024). Effect sizes were modest rather than dramatic, which is what you would expect from a supplement restoring a nutritional coenzyme rather than a pharmaceutical-level intervention.

What Did Individual Trials Show About Energy, Endurance, and Insulin Sensitivity?​

A 2021 randomized double-blind study in the Journal of the International Society of Sports Nutrition found that NMN supplementation improved maximal oxygen uptake (VO2 max) in amateur runners over 6 weeks of training plus supplementation, compared to placebo (Liao et al., J Int Soc Sports Nutr, 2021).

In a landmark 2021 Science paper, Yoshino and colleagues found that 10 weeks of 250 mg daily NMN in overweight postmenopausal women with prediabetes increased muscle insulin sensitivity and the expression of genes related to muscle remodeling - effects not seen with placebo (Yoshino et al., Science, 2021). That study was conducted in women, not men, and not in TRT populations, but the metabolic insulin sensitivity mechanism is directly relevant to men with insulin resistance who are also on TRT.

A 2022 safety study by Fukamizu and colleagues in healthy adults at 250 mg per day confirmed no adverse effects on liver function, kidney function, or blood parameters over 12 weeks, with meaningful increases in blood NAD+ confirmed by assay (Fukamizu et al., Sci Rep, 2022).

Men over 50 with lower baseline NAD+ levels appear to see the most measurable response. Community members under 40 with healthy metabolisms are less likely to notice a clinically significant benefit.

Can NMN Help with Inflammation, Joint Pain, and Immune Health?​

This is where the source material behind this article gets genuinely interesting - and where intellectual honesty requires a clear distinction between preclinical data and clinical evidence.

What Does the Rheumatoid Arthritis Research Actually Show?​

Preclinical research summarized in patent AU2020367387A1 shows that NMN - specifically in its zwitterionic form, where the molecule carries balanced opposite electrical charges - produces anti-inflammatory effects in the K/BxN mouse model of rheumatoid arthritis that are comparable to dexamethasone, a standard corticosteroid. The differentiator in the animal data: dexamethasone caused significant weight loss and systemic catabolic effects consistent with steroid toxicity. NMN-treated animals maintained weight while achieving similar reductions in joint swelling and clinical scores.

This is animal data derived from a patent application. It is not a clinical trial, and patent evidence is not peer-reviewed. What the data does establish is a biologically coherent mechanism: replenishing intracellular NAD+ may reduce synovial inflammation by restoring cellular energy homeostasis in the joint capsule - moving the intervention from symptom suppression to metabolic restoration. The K/BxN mouse model is a validated preclinical tool for early RA research.

For men on TRT with inflammatory joint symptoms - not uncommon given the typical age profile of the community - this is a hypothesis worth tracking over the next few years as human trials proceed. NMN is not an established RA therapy in humans, and it should not be positioned as one.

What Is the HIV Immune Recovery Study?​

A registered proof-of-concept clinical trial (NCT06889142) is designed to investigate whether NMN supplementation can improve CD4+ T cell recovery in HIV patients with immunological failure - a condition where viral suppression has been achieved on antiretroviral therapy but immune cell counts fail to normalize. The hypothesis is that NAD+ restoration improves T cell function and mitochondrial health in chronically depleted immune cells.

This trial is registered but had not yet enrolled participants as of the most recent status update. Results are not available. For long-term TRT users in the ExcelMale community who also live with HIV - a population this forum has advocated for over 30 years - this is a research direction worth following. It is not current evidence for NMN's effects on immune function.

What Is the Difference Between NMN, NR, Niacinamide, and NMNH?​

Men researching NAD+ supplementation quickly run into four main options. Here is what distinguishes them in practice.

Precursor	Pathway	Key Consideration
Niacinamide (NAM)	Salvage pathway	Cheapest option; inhibits sirtuins at high doses; may be adequate for younger men with healthy metabolism
Nicotinamide Riboside (NR)	NRK pathway	Well-studied; FDA GRAS status confirmed; widely available and competitively priced
NMN	NRK (via NR conversion)	FDA-confirmed legal as dietary supplement since September 29, 2025; robust RCT data; 500-1,000 mg standard range
NMNH (Reduced NMN)	Adenosine kinase (AK) pathway	Up to 10x more potent than NMN in preclinical studies; bypasses rate-limiting steps; limited human data; no FDA NDI clearance yet

The niacinamide debate in the ExcelMale community is worth acknowledging directly. Some researchers and forum members argue that all these precursors converge on niacinamide in the liver anyway, making the more expensive options poor value. That argument has real merit for younger men at lower doses. For men over 50 with documented NAD+ decline and metabolic compromise, the superior bioavailability data for NMN and NR suggests they convert more efficiently to usable intracellular NAD+ than niacinamide does at equivalent doses.

NMNH (Dihydronicotinamide Mononucleotide) is the most potent NAD+ precursor currently available based on the emerging research. A 2021 FASEB Journal study by Zapata-Perez and colleagues confirmed that NMNH raises NAD+ faster and to greater levels than NMN or NR in mammalian cells and mice, using a distinct adenosine kinase (AK) pathway that bypasses the rate-limiting enzymatic steps that can blunt conventional NMN conversion (Zapata-Perez et al., FASEB J, 2021). One industry-funded Phase I trial using a branded NMNH product (UthPeak, EffePharm) in 80 healthy adults reported a 3x increase in NAD+ levels sustained for up to 20 hours. The human evidence base for NMNH is thin; it is an early-stage option with promising preclinical data, not an established supplement with the same RCT backing as NMN.

What Dose and Form of NMN Are Men on TRT Actually Using?​

Clinical trials have used doses ranging from 250 mg to 1,200 mg per day. The Fukamizu 2022 safety paper confirmed 250 mg daily produces no adverse effects in healthy adults. Performance trials have used larger doses in the 500-1,200 mg range. The practical range for most men in the ExcelMale community is 500 to 1,000 mg daily.

Most users take NMN in the morning on an empty stomach. NMN degrades in stomach acid at low pH, which is why gastroresistant formulations and sublingual delivery are common. Sublingual administration bypasses first-pass liver metabolism, where oral NMN is largely converted to niacinamide before reaching other tissues. No published head-to-head trial compares sublingual versus oral NMN in humans, so the sublingual advantage remains biologically plausible but not confirmed by controlled study.

TMG (trimethylglycine) is commonly co-administered with NMN at a 1:1 ratio. High-dose NAD+ precursors act as "methyl sinks" - they consume methyl groups during metabolism, which may deplete circulating methyl donors over time. TMG provides those methyl groups. This combination appears frequently in ExcelMale supplement stack discussions and in the Sinclair protocol.

One practical note from the patent literature: The research behind the rheumatoid arthritis application identifies several compounds that should not be combined with NMN in high-dose therapeutic contexts - including resveratrol, metformin, berberine, folate, and SAM. The mechanism is methyl group competition in the salvage pathway. This contraindication applies primarily at high therapeutic doses used in the RA patent protocol. Many community members use NMN alongside resveratrol at standard supplement doses without reported problems. It is worth being aware of at higher doses.

Is NMN Legal in the US After the September 2025 FDA Reversal?​

Yes. On September 29, 2025, the FDA confirmed in letters to the Natural Products Association that NMN is lawful as a dietary supplement in the United States. This ended nearly three years of regulatory confusion dating from November 2022, when the FDA initially excluded NMN from the dietary supplement category because it had been authorized for investigation as a new drug (MIB-626, investigated by MetroBiotech).

The reversal centered on evidence that NMN was already being marketed as a dietary supplement in the United States as early as 2017 - before the drug investigation was authorized. Under the DSHEA "race to market" provision, that prior marketing history protects the ingredient's supplement classification.

NMN remains classified as a New Dietary Ingredient (NDI), meaning companies must still submit an NDI notification to the FDA before marketing it. For consumers, the practical result is that NMN products are available again from legitimate supplement companies and major retailers. During the gray-market sourcing period of 2022-2025, product quality and purity varied considerably. Purchase from companies that provide third-party certificates of analysis.

Frequently Asked Questions​

Does NMN raise testosterone levels in men?​

No. NMN has no established mechanism for affecting testosterone production. Its value alongside TRT comes from supporting cellular energy and potentially reducing chronic inflammation - parallel pathways to testosterone that do not overlap with hormonal signaling. Men looking to optimize both the hormonal and cellular energy layers are the appropriate target for NMN supplementation.

Is NMN worth taking if I am already optimized on TRT?​

That depends on age and goals. For men under 40 with solid metabolic health, the incremental benefit is probably small. For men over 50 with lower baseline NAD+ levels, the published evidence supports meaningful benefits for physical performance and muscle insulin sensitivity. Quality NMN at 500 mg daily costs roughly $40-60 per month, which many men in the ExcelMale community consider reasonable relative to the evidence base.

How long does NMN take to produce noticeable effects?​

Blood NAD+ levels rise within a few weeks of starting NMN. Physical performance and metabolic changes typically require 8 to 12 weeks to become apparent. Community members who report subjective energy and sleep improvements generally notice changes within 2 to 4 weeks. If no change is apparent after 12 weeks at 500 mg or higher, reassess the dose and formulation before concluding it is not effective.

Should I take NMN with or without food?​

Most clinical studies and community protocols use morning dosing on an empty stomach. NMN degrades in gastric acid, so avoiding food that stimulates acid production before dosing is sensible. If you use a standard capsule formulation, a gastroresistant (enteric-coated) version reduces degradation in the stomach. If you use sublingual powder, dissolve it under the tongue and hold for 60 to 90 seconds before swallowing.

Is NMNH worth trying over standard NMN?​

Not yet for most men. The preclinical data on NMNH's potency advantage is compelling, but the human evidence base is limited to one industry-funded Phase I trial. NMNH also lacks FDA NDI clearance, meaning its regulatory status is less settled than NMN's. Standard NMN has the better evidence-to-risk ratio today. NMNH is worth revisiting as human trial data accumulates over the next two to three years.

Conclusion​

Here is what the supplement guides typically leave out: the men who report the clearest benefits from NMN are consistently over 50, not men in their 30s. That is not a coincidence - it reflects the age at which the NAD+ decline becomes clinically meaningful and the conversion enzymes become less efficient. If you are 42 with solid metabolic health and optimized TRT, the lift from NMN may be real but subtle. If you are 58 with residual fatigue that testosterone has not fully resolved, restoring the cellular energy infrastructure beneath the hormonal layer is a more compelling clinical rationale.

The September 2025 FDA regulatory resolution removed the biggest practical barrier to purchasing quality NMN in the US. The preclinical inflammation data and the pending HIV immune recovery trial represent potentially significant expansions of the evidence base over the next several years. This is a supplement where the honest recommendation is: evidence supports trying it, particularly for men over 50, with realistic expectations and proper sourcing.

For deeper reading on NAD+ and longevity protocols in the ExcelMale library, see the community discussions linked below. For men combining NMN with growth hormone secretagogues like CJC-1295 and ipamorelin, the ExcelMale GH peptide guide covers how mitochondrial and GH optimization pathways interact.

Related ExcelMale Forum Discussions​

1. NAD, Hype Or Miracle Molecule? - The foundational ExcelMale debate on NAD+ supplementation, including early skepticism about NMN versus niacinamide and the economics of each option.
2. This NMN Supplement Hype - Community thread sorting signal from noise on NMN, with member-reported dosing protocols, sublingual delivery experiences, and TMG co-administration practices.
3. Increasing NAD+ - Early ExcelMale resource on NAD+ biology, covering precursor options, conversion pathway debates, and links to foundational research including the Sinclair mouse endurance studies.
4. The New Standard in NAD-Boosting - Community discussion of next-generation NAD+ approaches including intravenous Niagen protocols and the role of CD38-inhibiting compounds like apigenin.
5. The Anti-Aging Supplements David Sinclair Takes - Thread covering Sinclair's full longevity stack including NMN dosages, resveratrol co-administration rationale, and community reactions to the evidence.
6. David Sinclair, Ph.D., on Rogan - Discussion of Sinclair's Joe Rogan appearance that introduced many ExcelMale members to NMN, including healthy skepticism about sirtuins and the early data.
7. What Other Supplements Are You Taking in Addition to Your TRT Regimen? - Long-running community thread where members list their full supplement stacks alongside TRT, including multiple NMN and TMG protocols from men over 50.
8. Methylene Blue Pros and Cons - Extended community discussion of mitochondrial supplements, including direct comparison of NMN versus methylene blue mechanisms and how they are used together.

Key References​

1. Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464-471. DOI
2. Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. DOI
3. Zapata-Perez R, Wanders RJA, van Karnebeek CDM, Houtkooper RH. Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice. FASEB J. 2021;35(4):e21580. DOI
4. Fukamizu Y, Uchida Y, Shigekawa A, Sato T, Kosaka H, Sakurai T. Safety evaluation of beta-nicotinamide mononucleotide oral administration in healthy adult men and women. Sci Rep. 2022;12(1):14442. DOI
5. Wen J, Syed B, Kim S, et al. Improved physical performance parameters in patients taking nicotinamide mononucleotide (NMN): a systematic review of randomized control trials. Cureus. 2024;16(8):e65961. DOI
6. Liao B, Zhao Y, Wang D, et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2021;18(1):54. DOI
7. Patent AU2020367387A1. Use of NMN and NMNH for treating inflammatory joint diseases including rheumatoid arthritis. Australian Patent Office. Filed 2020; published 2022. Patent
8. Natural Products Association. FDA Reinstates NMN as Dietary Supplement After NPA Lawsuit. NPA Press Release. December 10, 2025. Source

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting or modifying any hormone therapy, supplement regimen, or medical treatment.

About ExcelMale​

ExcelMale.com is a peer-to-peer men's health community with more than 24,000 members and over 20 years of archived discussion on testosterone replacement therapy, hormone optimization, sexual health, peptides, and related topics. Founded by Nelson Vergel - chemical engineer, long-term TRT patient, and patient advocate - ExcelMale provides evidence-based information that bridges the gap between clinical research and real-world experience.

Nelson Vergel is the author of Testosterone: A Man's Guide and Beyond Testosterone, widely used references in the TRT community. He is also the founder of DiscountedLabs.com, a resource for affordable direct-to-consumer hormone and health laboratory testing.

ExcelMale.com | Men's Health Forum

---
FAQ Schema (JSON-LD for web posting - paste in page header if supported):

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Does NMN raise testosterone levels in men?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No. NMN has no established mechanism for affecting testosterone production. Its value alongside TRT comes from supporting cellular energy and potentially reducing chronic inflammation - parallel pathways to testosterone that do not overlap with hormonal signaling."
      }
    },
    {
      "@type": "Question",
      "name": "Is NMN worth taking if I am already optimized on TRT?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "That depends on age and goals. For men under 40 with solid metabolic health, the incremental benefit is probably small. For men over 50 with lower baseline NAD+ levels, the published evidence supports meaningful benefits for physical performance and muscle insulin sensitivity."
      }
    },
    {
      "@type": "Question",
      "name": "How long does NMN take to produce noticeable effects?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Blood NAD+ levels rise within a few weeks of starting NMN. Physical performance and metabolic changes typically require 8 to 12 weeks to become apparent. If no change is apparent after 12 weeks at 500 mg or higher, reassess the dose and formulation."
      }
    },
    {
      "@type": "Question",
      "name": "Should I take NMN with or without food?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Most clinical studies and community protocols use morning dosing on an empty stomach. NMN degrades in gastric acid, so gastroresistant or sublingual formulations improve delivery. If using sublingual powder, dissolve under the tongue and hold for 60 to 90 seconds before swallowing."
      }
    },
    {
      "@type": "Question",
      "name": "Is NMNH worth trying over standard NMN?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Not yet for most men. The preclinical data on NMNH's potency advantage is compelling, but the human evidence base is limited to one industry-funded Phase I trial. NMNH also lacks FDA NDI clearance. Standard NMN has the better evidence-to-risk ratio today."
      }
    }
  ]
}
</script>